A Ng P F Ravetto G M Taylor R F Wynn O B Eden
10.1038/sj.bjc.6602269
Br J Cancer
2004 Dec 13;91(12):1990-2.
CC BY
https://pubmed.ncbi.nlm.nih.gov/15570305/
Antineoplastic Combined Chemotherapy Protocols / adverse effects DNA-Binding Proteins / genetics Histiocytosis, Non-Langerhans-Cell / drug therapy Leukemia, Myelomonocytic, Acute / etiology Neoplasms, Second Primary / genetics Nucleic Acid Synthesis Inhibitors / adverse effects Proto-Oncogenes / genetics Transcription Factors / genetics
Antineoplastic Combined Chemotherapy Protocols / adverse effects DNA-Binding Proteins / genetics Histiocytosis, Non-Langerhans-Cell / drug therapy Leukemia, Myelomonocytic, Acute / etiology Neoplasms, Second Primary / genetics Nucleic Acid Synthesis Inhibitors / adverse effects Proto-Oncogenes / genetics Transcription Factors / genetics Case Reports Blotting, Southern Dexamethasone / administration & dosage Epstein-Barr Virus Infections / complications Etoposide / adverse effects Gene Rearrangement Histiocytosis, Non-Langerhans-Cell / etiology Histone-Lysine N-Methyltransferase Humans Infant Male Methotrexate / administration & dosage Myeloid-Lymphoid Leukemia Protein Polymerase Chain Reaction Time Factors Topoisomerase II Inhibitors DNA-Binding Proteins KMT2A protein, human Nucleic Acid Synthesis Inhibitors Topoisomerase II Inhibitors Transcription Factors Myeloid-Lymphoid Leukemia Protein Etoposide Dexamethasone Histone-Lysine N-Methyltransferase Methotrexate
PMC2409780
15570305
Coexistence of treatment-related MLL cleavage and rearrangement in a child with haemophagocytic lymphohistiocytosis
2004